Long-term Experience with Anti- Tumor Necrosis Factor-α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior and Panuveitis

被引：0
|
作者：
Amer, Radgonde [1 ]
Vofo, Brice Nguedia [1 ]
Corredores, Jamel [1 ]
机构：
[1] Hadassah Med Ctr, Ophthalmol, Jerusalem, Israel
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3193-A0419
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis
    Doycheva, Deshka
    Zierhut, Manfred
    Blumenstock, Gunnar
    Stuebiger, Nicole
    Deuter, Christoph
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (08) : 1235 - 1243
  • [22] Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis
    Deshka Doycheva
    Manfred Zierhut
    Gunnar Blumenstock
    Nicole Stuebiger
    Christoph Deuter
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249
  • [23] Effectiveness of Anti-Tumor Necrosis Factor-α Agents in the Treatment of Refractory Juvenile Dermatomyositis
    Boulter, E. L.
    Beard, L.
    Ryder, Clive
    Pilkington, Clarissa
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S795 - S795
  • [24] Short-term treatment with monoclonal anti-tumor necrosis factor-α antibody in refractory long-standing rheumatoid arthritis.
    Fantini, F
    Sinigaglia, L
    Zeni, S
    Cagnoli, M
    Favalli, EG
    Colombelli, P
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S227 - S227
  • [25] Long-term clinical and real-world experience with Crohn's disease treated with anti-tumor necrosis factor-α antibodies
    Otake, Haruka
    Matsumoto, Satohiro
    Mashima, Hirosato
    [J]. INTESTINAL RESEARCH, 2022, 20 (04) : 464 - 474
  • [26] Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-α therapy
    Yee, AMF
    Pochapin, MB
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (01) : 27 - 31
  • [27] Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
    Utz, Virginia Miraldi
    Bulas, Sabrina
    Lopper, Sarah
    Fenchel, Matthew
    Sa, Ting
    Mehta, Mitul
    Ash, Daniel
    Lovell, Daniel J.
    Kaufman, Adam H.
    [J]. PEDIATRIC RHEUMATOLOGY, 2019, 17 (01)
  • [28] Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
    Fabiani, Claudia
    Vitale, Antonio
    Rigante, Donato
    Emmi, Giacomo
    Bitossi, Alice
    Lopalco, Giuseppe
    Sota, Jurgen
    Guerriero, Silvana
    Orlando, Ida
    Gentileschi, Stefano
    Iannone, Florenzo
    Frediani, Bruno
    Galeazzi, Mauro
    Vannozzi, Lorenzo
    Tosi, Gian Marco
    Cantarini, Luca
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (02) : 407 - 415
  • [29] Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
    Claudia Fabiani
    Antonio Vitale
    Donato Rigante
    Giacomo Emmi
    Alice Bitossi
    Giuseppe Lopalco
    Jurgen Sota
    Silvana Guerriero
    Ida Orlando
    Stefano Gentileschi
    Florenzo Iannone
    Bruno Frediani
    Mauro Galeazzi
    Lorenzo Vannozzi
    Gian Marco Tosi
    Luca Cantarini
    [J]. Clinical Rheumatology, 2019, 38 : 407 - 415
  • [30] Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis
    Virginia Miraldi Utz
    Sabrina Bulas
    Sarah Lopper
    Matthew Fenchel
    Ting Sa
    Mitul Mehta
    Daniel Ash
    Daniel J. Lovell
    Adam H. Kaufman
    [J]. Pediatric Rheumatology, 17
12345